マーケットレポート詳細
ECMO（体外式膜型人工肺）の世界市場：2026年に至るモダリティ別、用途別予測
Extracorporeal Membrane Oxygenation Machine Market by Product, Component, Patient Type (Neonates, Pediatrics and Adults), Modality Outlook (Veno-Venous, Veno-Arterio and Arterio-Venous), Applications, and Region - Global Forecast to 2026
- 出版元：MarketsandMarkets
出版元について - 発行年：2021年11月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文169ページになります。
- 商品コード：MAM2758
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
ECMO（体外式膜型人工肺）の世界市場規模は2021年で5億3100万ドル、2026年には6億7300万ドルへと拡大し、市場の平均年成長率は4.9%で推移する見込みです。
ECMO（体外式膜型人工肺）のセグメント別市場では、用途別で呼吸器用途、モダリティ別で動静脈ECMO(AV)が2020年に最大のシェアを占めました。
レポートはECMO（体外式膜型人工肺）の世界市場について2026年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、コンポーネント別市場、等）を中心に構成されています。また競合状況、主要企業情報（20社）、COVID-19によるECMO（体外式膜型人工肺）市場への影響、特許分析などの分析も加味し、ECMO（体外式膜型人工肺）市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆ECMO（体外式膜型人工肺）の世界市場予測2018-2026年
・市場規模(US$)
◆製品別、市場-2026年
ECMO
・ポータブルECMO
・固定型ECMO
ソフトウェア
※(市場規模US$)
◆コンポーネント別、市場-2026年
・ポンプ
・酸素供給器
・コントローラ
・カニューレ
・アクセサリ
※(市場規模US$)
◆モダリティ別、市場-2026年
・静動脈ECMO (VA)
・静脈ECMO (VV)
・動静脈ECMO （AV）
※(市場規模US$)
◆患者タイプ別、市場-2026年
・新生児
・小児患者
・成人
※(市場規模US$)
◆用途別、市場-2026年
・呼吸器用途
・心臓用途
・体外心肺蘇生法(ECPR)
※(市場規模US$)
◆主要国地域別市場-2026年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域別に全セグメント別の細分化データ掲載、詳細は目次参照
※国別に製品別の細分化データ掲載
◆市場分析
・市場ダイナミクス（ドライバー、障壁、機会、課題）
・COVID-19によるECMO（体外式膜型人工肺）市場への影響
・特許分析
・バリューチェーン分析
・ファイブフォース分析
・市場シェア分析
・競合状況
◆ECMO（体外式膜型人工肺）の主要企業プロフィール動向
・FRESENIUS MEDICAL CARE AG & CO. KGAA
・GETINGE GROUP
・MEDTRONIC PLC
・MICROPORT
・TERUMO CARDIOVASCULAR SYSTEMS CORPORATION
・ニプロ株式会社
・LIVANOVA PLC
・EUROSETS S.R.L.
・ORIGEN BIOMEDICAL, INC.
・CYTOSORBENTS CORPORATION
・ABIOMED
・BRAILE BIOMÉDICA
・SPECTRUM MEDICAL
・HAEMONETICS
・XENIOS AG
・株式会社カネカ
・SBカワスミ株式会社
・WEIGAO GROUP
・ZHENGYUAN TECHNOLOGY
・BREETHE, INC.
（全169頁）
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS & EXCLUSIONS OF THE STUDY 26
1.3 MARKETS SCOPE 26
1.3.1 MARKETS COVERED 26
・ FIGURE 1 ECMO MARKET SEGMENTATION 26
1.3.2 YEARS CONSIDERED FOR THE STUDY 27
1.4 CURRENCY USED FOR THE STUDY 27
1.5 KEY MARKET STAKEHOLDERS 27
1.6 SUMMARY OF CHANGES 28
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA 29
・ FIGURE 2 RESEARCH DESIGN 29
2.1.1 SECONDARY DATA SOURCES 30
2.1.1.1 INDICATIVE LIST OF SECONDARY SOURCES 31
2.1.2 PRIMARY DATA 32
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION AND REGION 33
2.2 MARKET SIZE ESTIMATION METHODOLOGY 33
・ FIGURE 4 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 34
2.3 MARKET DATA VALIDATION AND TRIANGULATION 35
・ FIGURE 5 DATA TRIANGULATION METHODOLOGY 35
2.4 KEY RESEARCH ASSUMPTIONS 36
2.5 LIMITATIONS 36
2.5.1 METHODOLOGY-RELATED LIMITATIONS 36
2.6 RISK ASSESSMENT 37
・ TABLE 1 RISK ASSESSMENT: ECMO MARKET 37
2.7 GROWTH RATE ASSUMPTIONS 37
2.8 COVID-19 HEALTH ASSESSMENT 37
2.9 COVID-19 ECONOMIC ASSESSMENT 37
2.10 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 38
・ FIGURE 6 CRITERIA IMPACTING THE GLOBAL ECONOMY 38
・ FIGURE 7 RECOVERY SCENARIO OF THE GLOBAL ECONOMY (2021–2022) 39
3 EXECUTIVE SUMMARY
・ FIGURE 8 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 40
・ FIGURE 9 ECMO MARKET SHARE, BY MODALITY, 2021 VS. 2026 40
・ FIGURE 10 ECMO MARKET, BY COMPONENT, 2021 VS. 2026 (USD MILLION) 41
・ FIGURE 11 GEOGRAPHICAL SNAPSHOT OF THE ECMO MARKET 42
4 PREMIUM INSIGHTS
4.1 ECMO MARKET OVERVIEW 43
・ FIGURE 12 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH 43
4.2 ECMO MARKET SHARE, BY REGION AND PATIENT TYPE (2020) 44
・ FIGURE 13 NORTH AMERICA DOMINATED THE ECMO MARKET IN 2020 44
4.3 ECMO MARKET, BY PRODUCT, 2021 VS. 2026 (USD MILLION) 44
・ FIGURE 14 ECMO MACHINES SEGMENT WILL CONTINUE TO DOMINATE
THE ECMO MARKET DURING THE FORECAST PERIOD 44
4.4 ECMO MARKET: GEOGRAPHIC SNAPSHOT 45
・ FIGURE 15 EMERGING MARKETS ARE ESTIMATED TO REGISTER HIGHER GROWTH RATES THAN DEVELOPED MARKETS 45
5 MARKET OVERVIEW
5.1 INTRODUCTION 46
5.2 MARKET DYNAMICS 46
・ FIGURE 16 ECMO MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46
5.2.1 DRIVERS 47
5.2.1.1 INCREASING PREVALENCE OF CARDIOVASCULAR AND RESPIRATORY DISEASES 47
・ TABLE 2 NUMBER OF DEATHS FROM CARDIOVASCULAR AND RESPIRATORY DISEASES ACROSS THE GLOBE, 1990 VS. 2019 47
5.2.1.2 GROWING ADOPTION OF ECMO IN LUNG TRANSPLANTATION PROCEDURES
5.2.1.3 GROWTH IN THE NUMBER OF ECMO CENTERS 48
・ TABLE 3 GLOBAL INCREASE IN THE NUMBER OF ECMO CENTERS 48
5.2.1.4 TECHNOLOGICAL ADVANCEMENTS IN ECMO MACHINES 48
5.2.2 RESTRAINTS 49
5.2.2.1 COMPLICATIONS ASSOCIATED WITH ECMO 49
5.2.2.2 HIGH COST OF ECMO PROCEDURES 49
・ TABLE 4 AVERAGE COST OF ECMO IN VARIOUS COUNTRIES 49
5.2.3 OPPORTUNITIES 50
5.2.3.1 INCREASING SURVIVAL RATES WITH ECMO 50
5.2.4 CHALLENGES 50
5.2.4.1 SHORTAGE OF SKILLED PROFESSIONALS 50
5.2.4.2 ELIGIBILITY ISSUES FOR ECMO 50
5.2.4.3 ISSUES RELATED TO SELECTING THE RIGHT EQUIPMENT 50
5.2.4.4 RISKS RELATED TO THE TRANSPORT OF ECMO PATIENTS 51
5.2.4.5 ISSUES RELATED TO TREATMENT DECISION-MAKING 51
5.3 REGULATORY LANDSCAPE 51
・ TABLE 5 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING
THE ECMO MARKET 51
5.3.1 NORTH AMERICA 52
5.3.1.1 US 52
・ TABLE 6 CLASSIFICATION OF MEDICAL DEVICES BY US FDA 52
5.3.1.2 CANADA 53
5.3.2 EUROPE 53
5.3.3 ASIA PACIFIC 53
5.3.3.1 INDIA 53
5.3.3.2 JAPAN 53
・ TABLE 7 CLASSIFICATION OF MEDICAL DEVICES AND THE REVIEWING BODY IN JAPAN 54
5.3.3.3 CHINA 54
・ TABLE 8 NMPA MEDICAL DEVICE CLASSIFICATION 55
5.4 COVID-19 IMPACT ON THE ECMO MARKET 55
5.4.1 REIMBURSEMENT SCENARIO 55
5.5 PATENT ANALYSIS 56
5.5.1 PATENTS GRANTED FOR ECMO MACHINES 56
・ TABLE 9 PATENTS GRANTED FROM 2016 TO 2021 57
5.5.2 PUBLICATION TRENDS FOR PATENTS ON ECMO MACHINES 57
・ TABLE 10 FILED PATENTS, 2000–2021 57
・ TABLE 11 GRANTED PATENTS, 2010–2021 58
・ TABLE 12 PUBLISHED PATENTS, 2016–2021 58
5.6 VALUE CHAIN ANALYSIS 58
・ FIGURE 17 VALUE CHAIN OF THE ECMO MARKET 59
5.7 PRICING TREND ANALYSIS 59
・ TABLE 13 AVERAGE PRICE OF ECMO, BY COUNTRY, 2020 (USD) 59
5.8 PORTER’S FIVE FORCES ANALYSIS 60
・ TABLE 14 ECMO MARKET: PORTER’S FIVE FORCES ANALYSIS 60
5.8.1 THREAT OF NEW ENTRANTS 60
・ FIGURE 18 THREAT OF NEW ENTRANTS 60
5.8.2 THREAT OF SUBSTITUTES 61
・ FIGURE 19 THREAT OF SUBSTITUTES 61
5.8.3 BARGAINING POWER OF SUPPLIERS 61
・ FIGURE 20 BARGAINING POWER OF SUPPLIERS 62
5.8.4 BARGAINING POWER OF BUYERS 62
・ FIGURE 21 BARGAINING POWER OF BUYERS 62
5.8.5 INTENSITY OF COMPETITIVE RIVALRY 63
・ FIGURE 22 INTENSITY OF COMPETITIVE RIVALRY 63
5.9 ECOSYSTEM LANDSCAPE 63
・ FIGURE 23 ECMO MARKET: ECOSYSTEM LANDSCAPE 64
6 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PRODUCT
6.1 INTRODUCTION 66
・ TABLE 15 ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 66
6.2 ECMO MACHINES 66
6.2.1 STATIC ECMO MACHINES SEGMENT TO DOMINATE
THE ECMO MACHINES MARKET 66
・ TABLE 16 ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 66
・ TABLE 17 ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION) 67
・ TABLE 18 ECMO MACHINES MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 67
・ TABLE 19 ECMO MACHINES MARKET, BY MODALITY, 2018–2026 (USD MILLION) 67
・ TABLE 20 ECMO MACHINES MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 68
・ TABLE 21 ECMO MACHINES MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 68
6.2.2 POR・ TABLE ECMO MACHINES 68
・ TABLE 22 POR・ TABLE ECMO MACHINES MARKET, BY REGION,
2018–2026 (USD MILLION) 68
・ TABLE 23 POR・ TABLE ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 69
・ TABLE 24 POR・ TABLE ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION) 69
・ TABLE 25 POR・ TABLE ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 69
・ TABLE 26 POR・ TABLE ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 70
6.2.3 STATIC ECMO MACHINES 70
・ TABLE 27 STATIC ECMO MACHINES MARKET, BY REGION, 2018–2026 (USD MILLION) 70
・ TABLE 28 STATIC ECMO MACHINES MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 70
・ TABLE 29 STATIC ECMO MACHINES MARKET, BY MODALITY,
2018–2026 (USD MILLION) 71
・ TABLE 30 STATIC ECMO MACHINES MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 71
・ TABLE 31 STATIC ECMO MACHINES MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 71
6.3 SOFTWARE 72
6.3.1 SOFTWARE SEGMENT TO GROW AT A STEADY CAGR DURING
THE FORECAST PERIOD 72
・ TABLE 32 ECMO SOFTWARE MARKET, BY REGION, 2018–2026 (USD MILLION) 72
・ TABLE 33 ECMO SOFTWARE MARKET, BY MODALITY, 2018–2026 (USD MILLION) 72
・ TABLE 34 ECMO SOFTWARE MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 72
・ TABLE 35 ECMO SOFTWARE MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 73
7 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY COMPONENT
7.1 INTRODUCTION 75
・ TABLE 36 ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 75
7.2 PUMPS 75
7.2.1 CENTRIFUGAL BLOOD PUMPS HAVE BECOME THE PUMP OF CHOICE FOR ADULT EXTRACORPOREAL LIFE SUPPORT 75
・ TABLE 37 ECMO MARKET FOR PUMPS, BY REGION, 2018–2026 (USD MILLION) 75
7.3 OXYGENATORS 76
7.3.1 PMP OXYGENATORS HAVE SIGNIFICANTLY LESS PRIMING VOLUME 76
・ TABLE 38 ECMO MARKET FOR OXYGENATORS, BY REGION, 2018–2026 (USD MILLION) 76
7.4 CONTROLLERS 76
7.4.1 CONTROLLERS ALLOW OPERATORS OF ECMO CIRCUITS TO ADJUST THE SETTINGS AS NEEDED 76
・ TABLE 39 ECMO MARKET FOR CONTROLLERS, BY REGION, 2018–2026 (USD MILLION) 77
7.5 CANNULAS 77
7.5.1 THE CHOICE OF CANNULAS IS IMPORTANT IN ECMO PROCEDURES 77
・ TABLE 40 ECMO MARKET FOR CANNULAS, BY REGION, 2018–2026 (USD MILLION) 77
7.6 ACCESSORIES 78
・ TABLE 41 ECMO MARKET FOR ACCESSORIES, BY REGION, 2018–2026 (USD MILLION) 78
8 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY MODALITY
8.1 INTRODUCTION 80
・ TABLE 42 ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 80
8.2 VENOARTERIAL ECMO 80
8.2.1 INCREASING INCIDENCE OF HEART-LUNG FAILURE TO DRIVE
THE GROWTH OF THIS MARKET SEGMENT 80
・ TABLE 43 VENOARTERIAL ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 81
8.3 VENOVENOUS ECMO 81
8.3.1 VENOVENOUS ECMO IS USED WHEN ADEQUATE
HEART FUNCTION IS AVAILABLE 81
・ TABLE 44 VENOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 81
8.4 ARTERIOVENOUS ECMO 82
8.4.1 ARTERIOVENOUS ECMO MACHINES ARE SMALLER AND MORE POR・ TABLE 82
・ TABLE 45 ARTERIOVENOUS ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 82
9 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY PATIENT TYPE
9.1 INTRODUCTION 84
・ TABLE 46 COMMON INDICATIONS FOR ECMO IN NEONATES, PEDIATRIC
PATIENTS, AND ADULTS 84
・ TABLE 47 ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 84
9.2 NEONATES 85
9.2.1 A LARGE NUMBER OF NEONATES ARE CARED FOR WITH ECMO WORLDWIDE 85
・ TABLE 48 ECMO MARKET FOR NEONATES, BY REGION, 2018–2026 (USD MILLION) 85
9.3 PEDIATRIC PATIENTS 86
9.3.1 PEDIATRIC PATIENTS FORM A LARGE PATIENT GROUP FOR ECMO PROCEDURES 86
・ TABLE 49 ECMO MARKET FOR PEDIATRIC PATIENTS, BY REGION,
2018–2026 (USD MILLION) 86
9.4 ADULTS 86
9.4.1 TECHNOLOGICAL ADVANCEMENTS ARE DRIVING THE USE
OF ECMO IN ADULT PATIENTS 86
・ TABLE 50 ECMO MARKET FOR ADULTS, BY REGION, 2018–2026 (USD MILLION) 87
10 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY APPLICATION
10.1 INTRODUCTION 89
・ TABLE 51 ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 89
10.2 RESPIRATORY APPLICATIONS 89
・ TABLE 52 ECMO MARKET FOR RESPIRATORY APPLICATIONS, BY REGION,
2018–2026 (USD MILLION) 89
10.2.1 RESPIRATORY APPLICATIONS FOR NEONATES 90
・ TABLE 53 NUMBER OF NEONATES RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS 90
10.2.2 RESPIRATORY APPLICATIONS FOR PEDIATRIC PATIENTS 90
・ TABLE 54 NUMBER OF PEDIATRIC PATIENTS RECEIVING ECMO SUPPORT FOR RESPIRATORY APPLICATIONS 90
10.2.3 RESPIRATORY APPLICATIONS FOR ADULTS 90
・ TABLE 55 NUMBER OF ADULTS RECEIVING ECMO SUPPORT
FOR RESPIRATORY APPLICATIONS 90
10.3 CARDIAC APPLICATIONS 91
・ TABLE 56 ECMO MARKET FOR CARDIAC APPLICATIONS, BY REGION,
2018–2026 (USD MILLION) 91
10.3.1 CARDIAC APPLICATIONS FOR ADULTS 91
10.3.2 CARDIAC APPLICATIONS FOR PEDIATRIC PATIENTS 91
10.3.3 CARDIAC APPLICATIONS FOR NEONATES 91
10.4 EXTRACORPOREAL CARDIOPULMONARY RESUSCITATION (ECPR) 92
・ TABLE 57 ECMO MARKET FOR ECPR APPLICATIONS, BY REGION,
2018–2026 (USD MILLION) 92
10.4.1 ECPR APPLICATIONS FOR ADULTS 92
10.4.2 ECPR APPLICATIONS FOR PEDIATRIC PATIENTS 92
10.4.3 ECPR APPLICATIONS FOR NEONATES 93
11 EXTRACORPOREAL MEMBRANE OXYGENATION MARKET, BY REGION
11.1 INTRODUCTION 95
・ TABLE 58 ECMO MARKET, BY REGION, 2018–2026 (USD MILLION) 95
11.2 NORTH AMERICA 95
・ FIGURE 24 NORTH AMERICA: ECMO MARKET SNAPSHOT 96
・ TABLE 59 NORTH AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 96
・ TABLE 60 NORTH AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 97
・ TABLE 61 NORTH AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 97
・ TABLE 62 NORTH AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 97
・ TABLE 63 NORTH AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 98
・ TABLE 64 NORTH AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 98
・ TABLE 65 NORTH AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 98
11.2.1 US 99
11.2.1.1 US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN MARKET 99
・ TABLE 66 US: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 99
・ TABLE 67 US: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 99
11.2.2 CANADA 100
11.2.2.1 IMPLEMENTATION OF THE ABF MODEL IN CANADIAN HOSPITALS TO DRIVE MARKET GROWTH 100
・ TABLE 68 CANADA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 100
・ TABLE 69 CANADA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 100
11.3 EUROPE 101
・ TABLE 70 EUROPE: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 101
・ TABLE 71 EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 101
・ TABLE 72 EUROPE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 101
・ TABLE 73 EUROPE: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 102
・ TABLE 74 EUROPE: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 102
・ TABLE 75 EUROPE: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 102
・ TABLE 76 EUROPE: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 103
11.3.1 GERMANY 103
11.3.1.1 INCREASING VOLUME OF ECMO PROCEDURES TO DRIVE MARKET
GROWTH IN GERMANY 103
・ TABLE 77 GERMANY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 103
・ TABLE 78 GERMANY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 103
11.3.2 FRANCE 104
11.3.2.1 RISING HEALTHCARE SPENDING TO DRIVE MARKET GROWTH IN FRANCE 104
・ TABLE 79 FRANCE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 104
・ TABLE 80 FRANCE: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 104
11.3.3 UK 104
11.3.3.1 RISING ADOPTION OF ECMO PROCEDURES AND INCREASING PREVALENCE OF LIFESTYLE DISEASES TO DRIVE MARKET GROWTH IN THE UK 104
・ TABLE 81 UK: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 105
・ TABLE 82 UK: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 105
11.3.4 ITALY 105
11.3.4.1 HIGH BURDEN OF CVDS CONTRIBUTING TO THE GROWTH OF THE ECMO MARKET IN ITALY 105
・ TABLE 83 ITALY: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 106
・ TABLE 84 ITALY: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 106
11.3.5 SPAIN 106
11.3.5.1 HIGH ADOPTION OF ADVANCED TECHNOLOGIES TO DRIVE MARKET
GROWTH IN SPAIN 106
・ TABLE 85 SPAIN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 107
・ TABLE 86 SPAIN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 107
11.4 REST OF EUROPE 107
・ TABLE 87 REST OF EUROPE: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 107
・ TABLE 88 REST OF EUROPE: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 108
11.5 ASIA PACIFIC 108
・ FIGURE 25 ASIA PACIFIC: ECMO MARKET SNAPSHOT 108
・ TABLE 89 ASIA PACIFIC: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 109
・ TABLE 90 ASIA PACIFIC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 109
・ TABLE 91 ASIA PACIFIC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 109
・ TABLE 92 ASIA PACIFIC: ECMO MARKET, BY COMPONENT, 2018–2026 (USD MILLION) 110
・ TABLE 93 ASIA PACIFIC: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 110
・ TABLE 94 ASIA PACIFIC: ECMO MARKET, BY PATIENT TYPE, 2018–2026 (USD MILLION) 110
・ TABLE 95 ASIA PACIFIC: ECMO MARKET, BY APPLICATION, 2018–2026 (USD MILLION) 111
11.5.1 JAPAN 111
11.5.1.1 FAVORABLE HEALTHCARE INFRASTRUCTURE IN JAPAN TO DRIVE MARKET GROWTH 111
・ TABLE 96 JAPAN: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 111
・ TABLE 97 JAPAN: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 112
11.5.2 CHINA 112
11.5.2.1 RISING GERIATRIC POPULATION AND INCREASING PREVALENCE OF
CVD TO DRIVE MARKET GROWTH IN CHINA 112
・ TABLE 98 CHINA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 113
・ TABLE 99 CHINA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 113
11.5.3 INDIA 113
11.5.3.1 GROWING APPLICATIONS AND RISING ADOPTION OF ECMO TO DRIVE MARKET GROWTH IN INDIA 113
・ TABLE 100 INDIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 113
・ TABLE 101 INDIA: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 114
11.5.4 AUSTRALIA 114
11.5.4.1 TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET GROWTH IN AUSTRALIA 114
・ TABLE 102 AUSTRALIA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 114
・ TABLE 103 AUSTRALIA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 114
11.5.5 SOUTH KOREA 115
11.5.5.1 INCREASING INCIDENCE OF CARDIAC DISORDERS TO DRIVE MARKET GROWTH IN SOUTH KOREA 115
・ TABLE 104 SOUTH KOREA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 115
・ TABLE 105 SOUTH KOREA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 115
11.5.6 REST OF APAC 115
・ TABLE 106 REST OF APAC: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 116
・ TABLE 107 REST OF APAC: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 116
11.6 LATIN AMERICA 116
・ TABLE 108 LATIN AMERICA: ECMO MARKET, BY COUNTRY, 2018–2026 (USD MILLION) 116
・ TABLE 109 LATIN AMERICA: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 117
・ TABLE 110 LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 117
・ TABLE 111 LATIN AMERICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 117
・ TABLE 112 LATIN AMERICA: ECMO MARKET, BY MODALITY, 2018–2026 (USD MILLION) 118
・ TABLE 113 LATIN AMERICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 118
・ TABLE 114 LATIN AMERICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 118
11.6.1 BRAZIL 119
11.6.1.1 RISING ADOPTION OF ECMO AS A BRIDGE TO HEART AND LUNG TRANSPLANTATION TO DRIVE MARKET GROWTH IN BRAZIL 119
・ TABLE 115 BRAZIL: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 119
・ TABLE 116 BRAZIL: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 119
11.6.2 MEXICO 120
11.6.2.1 HIGH BURDEN OF CVDS IN THE COUNTRY TO DRIVE MARKET GROWTH IN MEXICO 120
・ TABLE 117 MEXICO: ECMO MARKET, BY PRODUCT, 2018–2026 (USD MILLION) 120
・ TABLE 118 MEXICO: ECMO MACHINES MARKET, BY TYPE, 2018–2026 (USD MILLION) 120
11.6.3 REST OF LATIN AMERICA 121
・ TABLE 119 REST OF LATIN AMERICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION) 121
・ TABLE 120 REST OF LATIN AMERICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 121
11.6.4 MIDDLE EAST & AFRICA 121
11.6.4.1 INCREASING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET GROWTH IN THE MIDDLE EAST & AFRICA 121
・ TABLE 121 MIDDLE EAST & AFRICA: ECMO MARKET, BY PRODUCT,
2018–2026 (USD MILLION) 122
・ TABLE 122 MIDDLE EAST & AFRICA: ECMO MACHINES MARKET, BY TYPE,
2018–2026 (USD MILLION) 122
・ TABLE 123 MIDDLE EAST & AFRICA: ECMO MARKET, BY COMPONENT,
2018–2026 (USD MILLION) 122
・ TABLE 124 MIDDLE EAST & AFRICA: ECMO MARKET, BY MODALITY,
2018–2026 (USD MILLION) 123
・ TABLE 125 MIDDLE EAST & AFRICA: ECMO MARKET, BY PATIENT TYPE,
2018–2026 (USD MILLION) 123
・ TABLE 126 MIDDLE EAST & AFRICA: ECMO MARKET, BY APPLICATION,
2018–2026 (USD MILLION) 123
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION 124
・ FIGURE 26 KEY DEVELOPMENTS BY LEADING PLAYERS IN THE ECMO MARKET,
2018–2021 124
12.2 REVENUE SHARE ANALYSIS 125
・ FIGURE 27 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET 125
12.3 MARKET SHARE ANALYSIS 126
・ FIGURE 28 ECMO MARKET SHARE, BY KEY PLAYER, 2020 126
・ TABLE 127 ECMO MARKET: DEGREE OF COMPETITION 126
12.4 COMPETITIVE LEADERSHIP MAPPING: COMPANY EVALUATION QUADRANT (2020) 127
12.4.1 TERMINOLOGY/NOMENCLATURE 127
12.4.1.1 STARS 127
12.4.1.2 EMERGING LEADERS 127
12.4.1.3 PERVASIVE PLAYERS 128
12.4.1.4 PARTICIPANTS 128
・ FIGURE 29 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING, 2020
12.5 COMPETITIVE LEADERSHIP MAPPING: START-UP/SME EVALUATION QUADRANT (2020) 129
12.5.1 PROGRESSIVE COMPANIES 129
12.5.2 RESPONSIVE COMPANIES 129
12.5.3 DYNAMIC COMPANIES 129
12.5.4 STARTING BLOCKS 129
・ FIGURE 30 ECMO MARKET: COMPETITIVE LEADERSHIP MAPPING FOR
SMES/START-UPS, 2020 130
12.6 COMPETITIVE BENCHMARKING 131
・ TABLE 128 PRODUCT FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ECMO MARKET 131
・ TABLE 129 APPLICATION FOOTPRINT ANALYSIS OF THE TOP PLAYERS
IN THE ECMO MARKET 132
・ TABLE 130 COMPANY FOOTPRINT ANALYSIS IN THE ECMO MARKET 133
12.7 COMPETITIVE SCENARIO (2018–2021) 134
12.7.1 NEW PRODUCT LAUNCHES & APPROVALS 134
13 COMPANY PROFILES
13.1 KEY PLAYERS 135
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS))*
13.1.1 FRESENIUS MEDICAL CARE AG & CO. KGAA 135
・ TABLE 131 FRESENIUS MEDICAL CARE AG & CO. KGAA: BUSINESS OVERVIEW 135
・ FIGURE 31 FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT 136
・ TABLE 132 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT OFFERINGS 136
・ TABLE 133 FRESENIUS MEDICAL CARE AG & CO. KGAA: PRODUCT LAUNCHES 137
13.1.2 GETINGE GROUP 138
・ TABLE 134 GETINGE GROUP: BUSINESS OVERVIEW 138
・ FIGURE 32 GETINGE GROUP: COMPANY SNAPSHOT 139
・ TABLE 135 GETINGE GROUP: PRODUCT OFFERINGS 140
13.1.3 MEDTRONIC PLC 141
・ TABLE 136 MEDTRONIC PLC: BUSINESS OVERVIEW 141
・ FIGURE 33 MEDTRONIC PLC: COMPANY SNAPSHOT 142
・ TABLE 137 MEDTRONIC PLC: PRODUCT OFFERINGS 142
13.1.4 MICROPORT 144
・ TABLE 138 MICROPORT: BUSINESS OVERVIEW 144
・ FIGURE 34 MICROPORT: COMPANY SNAPSHOT 145
・ TABLE 139 MICROPORT: PRODUCT OFFERINGS 145
13.1.5 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION 146
・ FIGURE 35 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: COMPANY SNAPSHOT 146
・ TABLE 140 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: BUSINESS OVERVIEW 147
・ TABLE 141 TERUMO CARDIOVASCULAR SYSTEMS CORPORATION: PRODUCT OFFERINGS 147
13.1.6 NIPRO CORPORATION 148
・ TABLE 142 NIPRO CORPORATION: BUSINESS OVERVIEW 148
・ FIGURE 36 NIPRO CORPORATION: COMPANY SNAPSHOT 149
・ TABLE 143 NIPRO CORPORATION: PRODUCT OFFERINGS 149
13.1.7 LIVANOVA PLC 150
・ TABLE 144 LIVANOVA PLC.: BUSINESS OVERVIEW 150
・ FIGURE 37 LIVANOVA PLC.: COMPANY SNAPSHOT 151
・ TABLE 145 LIVANOVA PLC: PRODUCT OFFERINGS 151
13.1.8 EUROSETS S.R.L. 152
・ TABLE 146 EUROSETS S.R.L.: BUSINESS OVERVIEW 152
・ TABLE 147 EUROSETS S.R.L.: PRODUCT OFFERINGS 152
13.1.9 ORIGEN BIOMEDICAL, INC. 153
・ TABLE 148 ORIGEN BIOMEDICAL, INC.: BUSINESS OVERVIEW 153
・ TABLE 149 ORIGEN BIOMEDICAL, INC.: PRODUCT OFFERINGS 153
13.1.10 CYTOSORBENTS CORPORATION 154
・ TABLE 150 CYTOSORBENTS CORPORATION: BUSINESS OVERVIEW 154
・ TABLE 151 CYTOSORBENTS CORPORATION: PRODUCT OFFERINGS 154
13.1.11 ABIOMED 155
・ TABLE 152 ABIOMED: BUSINESS OVERVIEW 155
・ TABLE 153 ABIOMED: PRODUCT OFFERINGS 155
13.1.12 BRAILE BIOMÉDICA 156
・ TABLE 154 BRAILE BIOMÉDICA: BUSINESS OVERVIEW 156
・ TABLE 155 BRAILE BIOMÉDICA: PRODUCT OFFERINGS 156
13.1.13 SPECTRUM MEDICAL 157
・ TABLE 156 SPECTRUM MEDICAL: BUSINESS OVERVIEW 157
・ TABLE 157 SPECTRUM MEDICAL: PRODUCT OFFERINGS 157
13.1.14 HAEMONETICS 158
・ TABLE 158 HAEMONETICS: BUSINESS OVERVIEW 158
・ TABLE 159 HAEMONETICS: PRODUCT OFFERINGS 158
13.1.15 XENIOS AG 159
・ TABLE 160 XENIOS AG: BUSINESS OVERVIEW 159
・ TABLE 161 XENIOS AG: PRODUCT OFFERINGS 159
・ TABLE 162 XENIOS AG: PRODUCT LAUNCHES 160
13.1.16 KANEKA CORPORATION 161
・ TABLE 163 KANEKA CORPORATION: BUSINESS OVERVIEW 161
・ TABLE 164 KANEKA CORPORATION: PRODUCT OFFERINGS 161
13.1.17 SB-KAWASUMI LABORATORIES, INC. 162
・ TABLE 165 SB-KAWASUMI LABORATORIES, INC.: BUSINESS OVERVIEW
・ TABLE 166 SB-KAWASUMI LABORATORIES, INC.: PRODUCT OFFERINGS
13.1.18 WEIGAO GROUP 163
・ TABLE 167 WEIGAO GROUP: BUSINESS OVERVIEW 163
・ TABLE 168 WEIGAO GROUP: PRODUCT OFFERINGS 163
13.1.19 ZHENGYUAN TECHNOLOGY 164
・ TABLE 169 ZHENGYUAN TECHNOLOGY: BUSINESS OVERVIEW
・ TABLE 170 ZHENGYUAN TECHNOLOGY: PRODUCT OFFERINGS
13.1.20 BREETHE, INC. 165
・ TABLE 171 BREETHE, INC.: BUSINESS OVERVIEW 165
・ TABLE 172 BREETHE, INC.: PRODUCT OFFERINGS 165
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS, AND MNM VIEW (KEY STRENGTHS/RIGHT TO WIN, STRATEGIC CHOICES MADE, AND WEAKNESSES AND COMPETITIVE THREATS) MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
14 APPENDIX